Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17420088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 69-yr-old man with bilateral and metastatic renal cell carcinoma developed progressive disease after interleukin-2 and interferon therapy. He was submitted to radical left nephrectomy, right nephron-sparing surgery, and bone metastasis removal, followed by therapy with sorafenib. At 12-mo follow-up there was a significant improvement in patient performance status and no evidence of clinical progression.
Medical subject headings
- Antineoplastic Agents
- Benzenesulfonates
- Bone Neoplasms
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Pyridines